STORY SUMMARY
FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppies
The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Simparica TRIO (sarolaner, moxidectin, and pyrantel chewable tablets) for the treatment of New World screwworm (NWS) infestations (myiasis) in dogs and puppies.
This is a brief summary of reporting from FDA Press Releases. Read the original for the full article and context.